Electrophysiologic effects of potassium canrenoate on ouabain-induced ventricular dysrhythmias in rabbits.
D000736:Androstenes / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D001794:Blood Pressure; D004562:Electrocardiography; D005260:Female; D007275:Injections, Intravenous; D008297:Male; D010042:Ouabain; D011188:Potassium / Q000008:administration & dosage / Q000627:therapeutic use; D011189:Potassium Chloride / Q000008:administration & dosage / Q000627:therapeutic use; D011817:Rabbits; D013610:Tachycardia / Q000139:chemically induced / Q000188:drug therapy*; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000188:drug therapy*
D000736:Androstenes; D010042:Ouabain; D011189:Potassium Chloride; D011188:Potassium